Recombinant Human Interleukin-2(Ⅰ) (Liaoning Satellite Biological Products)

重组人白介素-2(Ⅰ)（辽宁卫星）

Report date: 2022/03/10 14:41:35

Base Information

Drug NameRecombinant Human Interleukin-2(Ⅰ) (Liaoning Satellite Biological Products)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaNeoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2002/02/04
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLiaoning Satellite Biological Products Research Institute (Limited)
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Satellite Biological Products Research Institute (Limited)
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL03AC01
Related LinksN/A